Roche launches PHESGO in India
The dose is administered as a single injection just under the skin in the thigh
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Biological E seeks EUA for Corbevax as booster COVID-19 dose for adults
The Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein…
Fourth COVID-19 vaccine dose provides strong immunity boost: UK study
Fourth doses of COVID-19 vaccines have been offered as a spring booster for those most vulnerable in the UK, researchers said
Hetero unveils new logo and corporate brand identity
The new logo is effective immediately and will be implemented across the group’s companies, solutions, assets, services and…
AGI Greenpac releases financial results for Q4
In FY2022, the revenue from operations was of Rs 2,319 crores and Profit After Tax (PAT) grew from Rs 88 crores to Rs 193 crores
Inovio to discontinue COVID vaccine trial, appoints Jacqueline Shea as CEO
The decision on the trial comes after emerging global data showed a lower incidence of severe COVID cases, which would lead to an…
Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small…
The study evaluating Tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
Bayer relaunches antifungal brand Canesten in India
For over 40 years, Canesten has been helping people around the world to treat and prevent skin and foot infections
Alembic Pharma announces US FDA final approval for Arformoterol Tartrate Inhalation Solution
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Brovana Inhalation Solution, 15 mcg/2…
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop…
CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process…
Pfizer to buy Biohaven Pharma in $11.6 billion deal
Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6 per…
BioNTech completes phase-II trial of COVID-19 vaccine in China
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to…
Sun Pharma gets Form 483 from US FDA for regulatory violations at Halol plant
The US Food and Drug Administration (FDA) conducted a Good Manufacturing Practices (GMP) inspection of the Halol facility from…
Biologic sales to pass innovative small molecules in next five years: GlobalData
According to GlobalData’s report, ‘Future of Pharma—Looking Ahead to 2022’, biologics are forecast to significantly overtake…
Cipla partners with Genes2Me for commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR test kit
RNA extraction free kit to deliver results in 45 minutes
HSIL changes name to AGI Greenpac
The company has also changed the name of its PET business from Garden Polymers to AGI Plastek
Glenmark Pharma receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate…
The drug is the generic version of Enstilar Foam, 0.005%|0.064%, of Leo Pharma AS
Oral COVID vaccine protects against disease, transmission: Study
The research, published in the journal "Science Translational Medicine," demonstrates the potential of the vaccine to work through…
Lupin goes live with SAP S/4 HANA on HPE GreenLake to drive digital transformation
The company deploys HPE GreenLake edge-to-cloud platform to modernise mission-critical data centre applications and infrastructure
Regulatory framework for nutraceutical industry
Kavita Sharma, International Regulatory and Supply Chain Manager, Nutrify Today, explains why nutraceuticals require a more…